Repurposing of MitoTam: Novel Anti-Cancer Drug Candidate Exhibits Potent Activity against Major Protozoan and Fungal Pathogens

Author:

Arbon Dominik1,Ženíšková Kateřina1,Šubrtová Karolína1,Mach Jan1,Štursa Jan2,Machado Marta3,Zahedifard Farnaz1,Leštinová Tereza4,Hierro-Yap Carolina5,Neuzil Jiri267,Volf Petr4,Ganter Markus8,Zoltner Martin1,Zíková Alena59,Werner Lukáš2,Sutak Robert1ORCID

Affiliation:

1. Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic

2. Institute of Biotechnology, Czech Academy of Sciences, BIOCEV, Vestec, Czech Republic

3. Graduate Program in Areas of Basic and Applied Biology, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Portugal

4. Faculty of Sciences, Charles University, Department of Parasitology, Prague, Czech Republic

5. Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic

6. School of Pharmacy and Medical Science, Griffith University, Southport, Queensland, Australia

7. Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic

8. Centre for Infectious Diseases, Parasitology, Heidelberg University Hospital, Heidelberg, Germany

9. Faculty of Science, University of South Bohemia, České Budějovice, Czech Republic

Abstract

Many of the currently available anti-parasitic and anti-fungal frontline drugs have severe limitations, including adverse side effects, complex administration, and increasing occurrence of resistance. The discovery and development of new therapeutic agents is a costly and lengthy process.

Funder

Grantová Agentura České Republiky

The European Regional Development Fund and Ministry of Education, Youth and Sports of the Czech Republic

Grantová Agentura, Univerzita Karlova

Fundacio para a Ciencia e Tecnologia

Deutsche Forschungsgemeinschaft

Baden-Württemberg Stiftung

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3